Targeted Transcriptional Profiling of Microdissected Biopsy Specimens Representing Early Colonic Neoplasia

Allen Mo1, Stephen Jackson2, Thomas J Devers3

  • 1Center for Molecular Medicine, UConn Health, Farmington, Connecticut.

Insights

Studying early cancer development is hard. This research uses laser-capture microdissection and RNA sequencing to analyze gene activity in the earliest colorectal neoplasia (aberrant crypt foci) for better cancer prevention.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Understanding early tumor initiation is crucial for cancer prevention, but premalignant lesions are difficult to study.
  • Accurate genetic profiling of small lesions presents significant technical challenges.

Purpose of the Study:

  • To develop and validate a method for analyzing the transcriptional state of cells in early colorectal neoplasia.
  • To investigate the earliest detectable stage of human colorectal neoplasia, the aberrant crypt foci (ACF).

Main Methods:

  • Combined laser-capture microdissection (LCM) with targeted RNA-sequencing.
  • Developed a workflow for RNA isolation, library preparation, and expression profiling of laser-captured cells.
  • Utilized frozen OCT-embedded tissue specimens.

Main Results:

  • Successfully profiled the transcriptional state of epithelial and stromal cells within ACF.
  • Established a robust and reproducible workflow for microgenomic analysis of small tissue samples.

Conclusions:

  • The described methodological approach enables detailed analysis of early premalignant lesions.
  • This workflow provides a framework for microgenomics analyses applicable to various premalignant tissues.
  • Facilitates advancements in understanding and preventing cancer initiation.

Related Concept Videos